EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Biochemical Markers of Bone Fragility in Patients With Diabetes

Christian Meier iD, Richard Eastell iD, Dominique D Pierroz, Nancy E Lane, Nasser Al-Daghri, Atsushi Suzuki, Nicola Napoli, Ambrish Mithal, Marlene Chakhtoura, Ghada El-Hajj Fuleihan iD, Serge Ferrari iD

The Journal of Clinical Endocrinology & Metabolism · 18.09.2023 · 108 (10) · e923-e936

DOI: 10.1210/clinem/dgad255 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, online erschienen am 08.05.2023. Verfasst von Christian Meier und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Diabetology and Metabolism, University Hospital Basel, Switzerland. Die Arbeit wurde bisher 45-mal zitiert (Crossref) und nennt 192 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

The risk of fragility fractures is increased in both type 1 and type 2 diabetes. Numerous biochemical markers reflecting bone and/or glucose metabolism have been evaluated in this context.

Objective

This review summarizes current data on biochemical markers in relation to bone fragility and fracture risk in diabetes.

Methods

A group of experts from the International Osteoporosis Foundation and European Calcified Tissue Society reviewed the literature focusing on biochemical markers, diabetes, diabetes treatments, and bone in adults.

Results

Although bone resorption and bone formation markers are low and poorly predictive of fracture risk in diabetes, osteoporosis drugs seem to change bone turnover markers (BTMs) in diabetics similarly to nondiabetics, with similar reductions in fracture risk. Several other biochemical markers related to bone and glucose metabolism have been correlated with bone mineral density and/or fracture risk in diabetes, including osteocyte-related markers such as sclerostin, glycated hemoglobin A1c (HbA1c) and advanced glycation end products, inflammatory markers, and adipokines, as well as insulin-like growth factor-1 and calciotropic hormones.

Conclusion

Several biochemical markers and hormonal levels related to bone and/or glucose metabolism have been associated with skeletal parameters in diabetes. Currently, only HbA1c levels seem to provide a reliable estimate of fracture risk, while BTMs could be used to monitor the effects of antiosteoporosis therapy.

Schlagwörter

Stichwörter der Autor:innen

adipokineadvanced glycation endproductbone turnover markerdiabetessclerostin

Autor:innen und Institutionen

  • Department of Endocrinology, Diabetology and Metabolism, University Hospital Basel, Switzerland.
  • Academic Unit of Bone Metabolism, Mellanby Centre for Bone Research, University of Sheffield, Sheffield, UK.
  • International Osteoporosis Foundation (IOF), Nyon, Switzerland.
  • Department of Medicine and Rheumatology, Davis School of Medicine, University of California, Sacramento, CA, USA.
  • Chair for Biomarkers of Chronic Diseases, Department of Biochemistry, College of Science, King Saud University, Riyadh 11451, Saudi Arabia.
  • Department of Endocrinology, Diabetes and Metabolism, Fujita Health University, Toyoake, Aichi, Japan.

ORCID-Profile: Christian Meier, Richard Eastell, Ghada El-Hajj Fuleihan, Serge Ferrari

Zitieren

APA

Meier, C., Eastell, R., Pierroz, D. D., Lane, N. E., Al-Daghri, N., Suzuki, A., Napoli, N., Mithal, A., Chakhtoura, M., El-Hajj Fuleihan, G., & Ferrari, S. (2023). Biochemical Markers of Bone Fragility in Patients With Diabetes. The Journal of Clinical Endocrinology & Metabolism, 108(10), e923-e936. https://doi.org/10.1210/clinem/dgad255

Vancouver

Meier C, Eastell R, Pierroz DD, Lane NE, Al-Daghri N, Suzuki A, et al. Biochemical Markers of Bone Fragility in Patients With Diabetes. The Journal of Clinical Endocrinology & Metabolism. 2023;108(10):e923-e936. doi:10.1210/clinem/dgad255

BibTeX
@article{Meier2023,
  author = {Meier, Christian and Eastell, Richard and Pierroz, Dominique D and Lane, Nancy E and Al-Daghri, Nasser and Suzuki, Atsushi and Napoli, Nicola and Mithal, Ambrish and Chakhtoura, Marlene and El-Hajj Fuleihan, Ghada and Ferrari, Serge},
  title = {Biochemical Markers of Bone Fragility in Patients With Diabetes},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2023},
  volume = {108},
  number = {10},
  pages = {e923--e936},
  doi = {10.1210/clinem/dgad255}
}
Kostenlos starten →